@inproceedings{kulzer2018_47026,
  title = {More Patients with Optimal Glycemic Control after Participation in a CSII-Specific Education Program (INPUT)—Results from a Randomized Controlled Study},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  volume = {67},
  number = {Suppl. 1},
  pages = {A176 (671-P)},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db18-671-P},
  url = {https://fis.uni-bamberg.de/handle/uniba/47026},
  language = {eng},
  abstract = {Despite the technological advances of CSII-therapy, many patients with CSII-therapy do not achieve optimal glycemic control. We developed an education program for CSII-therapy (INPUT) and evaluated its efficacy in a randomized controlled trial with a six-month follow-up. INPUT addresses the specific knowledge and skills to effectively handle CSII-therapy as well as possible psychological barriers.
We analyzed whether participation in the INPUT program increased the number of patients with optimal glycemic control (HbA1c < 7.5\%).
254 patients with CSII-therapy were randomized to either receive the INPUT education program or treatment-as-usual and assessed at follow-up. All patients were already performing CSII-therapy for 8.7 ± 6.8 years, with a mean diabetes duration of 23.1 ± 12.6 years. HbA1c at baseline was 8.3 ± 0.9\%. Optimal glycemic control at baseline was achieved by 13\% in the INPUT group and 20\% in the control group.
Logistic regression with group as independent factor controlling for optimal glycemic control at baseline was performed. Dependent variable was optimal glycemic control at the six-month followup.
Group was a significant predictor with INPUT patients having a 2-fold higher chance to achieve optimal glycemic control (OR = 1.98; 95\% CI 1.04 – 3.78; p = 0.037) compared to patients in the control group. At follow-up, 27\% of the INPUT group had achieved optimal glycemic control while only 18 \% in the control group.
In this study, patients performed CSII-therapy for almost 10 years without achieving optimal glycemic control. After participation in INPUT, patient more often achieved optimal glycemic control compared to a treatment-as-usual control group. Thus, the INPUT education program was effective in improving glycemic control in patients with long-standing diabetes. Considering the higher costs of CSII-therapy, this beneficial effect of the education program has health-economic implications.}
}
